← Open Payments lookup

NNEKA ONUORAH: Open Payments

NPI 1881304905 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$511 in 22 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $474 · 2025 $511

Food & beverage: $511
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$122
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$102
ABBVIE INC.4$79
Lundbeck LLC3$67
Teva Pharmaceuticals USA, Inc.2$51
Takeda Pharmaceuticals U.S.A., Inc.2$47
Bausch Health US, LLC1$23
Otsuka America Pharmaceutical, Inc.1$19

Products named: INGREZZA, CAPLYTA, REXULTI, VRAYLAR, AUSTEDO XR, TRINTELLIX, WELLBUTRIN.

Industry payments across MD — which companies pay providers there.